Implanet Granted French Patent for Jazz Lock Implant

Implanet, a medical technology company specializing in vertebral and knee-surgery implants, announces that the French patent office has granted a patent protecting the Jazz Lock implant in France.
 
A major component of an innovative range of band products for spine surgery, Jazz Lock is an implant designed to treat degenerative spine disorders, whose global market potential is estimated at over $200 million.
 
Thanks to its locking system requiring no rod fixation, Jazz Lock allows surgeons to shorten and simplify the surgical procedure by removing multiple steps and implants used in traditional system: locking screws and connecting rods.
 
Régis Le Couedic, Implanet’s Product Development & Manufacturing Director, said: “Obtaining this patent from the French patent office is the first step in fully protecting our Jazz Lock, and more particularly, its locking mechanism that is the first of its kind in the market. The protection of this latter element is pivotal, insofar as the majority of our future developments will incorporate this technology. We continue to be extremely rigorous regarding the protection of our current and future innovations.”
 
Ludovic Lastennet, CEO of Implanet, added: “We are continuing the strict execution of our development strategy, of which the comprehensive protection of our products is a major component. We have submitted the dossier to various global intellectual property authorities, notably the United States. Since its limited launch last autumn in the United States and Europe, Implanet has sold more than 300 Jazz Lock implants to treat degenerative spine disorders. The clinical feedback from surgeons has been excellent, including important practical aspects such as ease of use and speed of implementation.”